Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Illness | 18 | 2017 | 2709 | 0.790 |
Why?
|
| Rheumatic Diseases | 4 | 2024 | 639 | 0.580 |
Why?
|
| Lung Diseases, Interstitial | 4 | 2024 | 911 | 0.510 |
Why?
|
| Rheumatology | 4 | 2024 | 611 | 0.490 |
Why?
|
| Vitamin D Deficiency | 9 | 2015 | 1379 | 0.410 |
Why?
|
| Autoimmune Diseases | 4 | 2024 | 2250 | 0.400 |
Why?
|
| Vitamin D | 10 | 2015 | 3291 | 0.390 |
Why?
|
| Interleukin-13 | 4 | 2006 | 371 | 0.340 |
Why?
|
| Glucocorticoids | 3 | 2024 | 2145 | 0.280 |
Why?
|
| Hospital Mortality | 10 | 2016 | 5418 | 0.270 |
Why?
|
| Tosyl Compounds | 1 | 2005 | 112 | 0.250 |
Why?
|
| Leukotriene Antagonists | 1 | 2005 | 123 | 0.240 |
Why?
|
| Budesonide | 1 | 2005 | 158 | 0.240 |
Why?
|
| Interferon-gamma | 4 | 2006 | 3157 | 0.220 |
Why?
|
| Sepsis | 8 | 2017 | 2592 | 0.200 |
Why?
|
| Critical Care | 11 | 2016 | 2699 | 0.200 |
Why?
|
| Community-Acquired Infections | 3 | 2014 | 461 | 0.190 |
Why?
|
| Prednisone | 1 | 2005 | 1566 | 0.180 |
Why?
|
| Intensive Care Units | 10 | 2017 | 3736 | 0.180 |
Why?
|
| Boston | 15 | 2017 | 9278 | 0.170 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2006 | 831 | 0.170 |
Why?
|
| Acute Kidney Injury | 3 | 2016 | 1941 | 0.150 |
Why?
|
| Smoke Inhalation Injury | 1 | 2017 | 47 | 0.140 |
Why?
|
| Logistic Models | 14 | 2017 | 13312 | 0.140 |
Why?
|
| Erythroblasts | 1 | 2017 | 143 | 0.140 |
Why?
|
| Hospitalization | 9 | 2017 | 10789 | 0.130 |
Why?
|
| Erythrocyte Indices | 2 | 2014 | 145 | 0.130 |
Why?
|
| Hypernatremia | 1 | 2016 | 78 | 0.130 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2006 | 1903 | 0.120 |
Why?
|
| Fetal Blood | 3 | 2006 | 1343 | 0.120 |
Why?
|
| Cross Infection | 2 | 2014 | 1434 | 0.120 |
Why?
|
| Odds Ratio | 10 | 2017 | 9716 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2006 | 1827 | 0.120 |
Why?
|
| Lung | 2 | 2015 | 9994 | 0.110 |
Why?
|
| Acid-Base Equilibrium | 1 | 2013 | 180 | 0.100 |
Why?
|
| Craniotomy | 1 | 2016 | 741 | 0.100 |
Why?
|
| Erythrocyte Volume | 1 | 2011 | 28 | 0.100 |
Why?
|
| Residence Characteristics | 2 | 2012 | 2061 | 0.100 |
Why?
|
| End Stage Liver Disease | 1 | 2016 | 353 | 0.100 |
Why?
|
| Pneumonia | 3 | 2015 | 2131 | 0.090 |
Why?
|
| Blood Urea Nitrogen | 1 | 2011 | 187 | 0.090 |
Why?
|
| Health Status Indicators | 2 | 2014 | 968 | 0.090 |
Why?
|
| Poverty Areas | 1 | 2012 | 264 | 0.090 |
Why?
|
| Scleroderma, Systemic | 2 | 2024 | 344 | 0.090 |
Why?
|
| Hyperkalemia | 1 | 2012 | 231 | 0.090 |
Why?
|
| Survivors | 2 | 2017 | 2375 | 0.080 |
Why?
|
| Middle Aged | 30 | 2017 | 220359 | 0.080 |
Why?
|
| Hospitals, Teaching | 4 | 2015 | 1166 | 0.080 |
Why?
|
| Aged | 25 | 2017 | 169143 | 0.070 |
Why?
|
| Male | 38 | 2017 | 359718 | 0.070 |
Why?
|
| Radiography, Thoracic | 1 | 2014 | 1296 | 0.070 |
Why?
|
| Clostridium Infections | 1 | 2014 | 557 | 0.070 |
Why?
|
| Bacteremia | 1 | 2013 | 980 | 0.070 |
Why?
|
| Asthma | 1 | 2005 | 6172 | 0.070 |
Why?
|
| Ofloxacin | 1 | 2006 | 66 | 0.070 |
Why?
|
| Risk Factors | 16 | 2017 | 74333 | 0.070 |
Why?
|
| Phenylcarbamates | 1 | 2005 | 37 | 0.070 |
Why?
|
| Phytohemagglutinins | 1 | 2005 | 168 | 0.060 |
Why?
|
| Female | 37 | 2017 | 391246 | 0.060 |
Why?
|
| Mortality | 1 | 2017 | 2916 | 0.060 |
Why?
|
| Cohort Studies | 11 | 2017 | 41337 | 0.060 |
Why?
|
| Burns | 1 | 2017 | 1866 | 0.060 |
Why?
|
| Multivariate Analysis | 6 | 2017 | 12159 | 0.060 |
Why?
|
| Tuberculin Test | 1 | 2006 | 206 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2015 | 1915 | 0.060 |
Why?
|
| Cause of Death | 2 | 2017 | 3725 | 0.060 |
Why?
|
| Creatinine | 1 | 2011 | 1904 | 0.060 |
Why?
|
| APACHE | 2 | 2017 | 267 | 0.060 |
Why?
|
| Tomography, Emission-Computed | 1 | 2008 | 1121 | 0.060 |
Why?
|
| Cerebral Hemorrhage | 1 | 2016 | 2660 | 0.060 |
Why?
|
| Hemoptysis | 1 | 2006 | 152 | 0.060 |
Why?
|
| Aged, 80 and over | 13 | 2016 | 58980 | 0.060 |
Why?
|
| Metronidazole | 1 | 2006 | 231 | 0.060 |
Why?
|
| Ventilator Weaning | 1 | 2006 | 161 | 0.060 |
Why?
|
| Mixed Connective Tissue Disease | 1 | 2024 | 32 | 0.060 |
Why?
|
| Patient Discharge | 2 | 2016 | 3474 | 0.060 |
Why?
|
| Humans | 42 | 2024 | 760613 | 0.060 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2006 | 125 | 0.060 |
Why?
|
| Adult | 21 | 2017 | 220007 | 0.060 |
Why?
|
| Patient Readmission | 2 | 2017 | 3322 | 0.060 |
Why?
|
| Language | 1 | 2013 | 1533 | 0.060 |
Why?
|
| Retrospective Studies | 15 | 2017 | 80345 | 0.060 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2006 | 463 | 0.060 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 4542 | 0.060 |
Why?
|
| Delirium | 1 | 2015 | 1663 | 0.050 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 2477 | 0.050 |
Why?
|
| Sjogren's Syndrome | 1 | 2024 | 235 | 0.050 |
Why?
|
| Sarcoidosis | 1 | 2008 | 520 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2005 | 1156 | 0.050 |
Why?
|
| Societies, Medical | 2 | 2024 | 3905 | 0.050 |
Why?
|
| Glucose | 3 | 1999 | 4350 | 0.050 |
Why?
|
| Endpoint Determination | 2 | 2015 | 597 | 0.050 |
Why?
|
| Myositis | 1 | 2024 | 269 | 0.050 |
Why?
|
| Confidence Intervals | 3 | 2011 | 2932 | 0.050 |
Why?
|
| Lymphocytes | 2 | 2006 | 2611 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2024 | 20509 | 0.050 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 2754 | 0.040 |
Why?
|
| Immune System | 1 | 2005 | 798 | 0.040 |
Why?
|
| Respiratory Function Tests | 1 | 2024 | 1683 | 0.040 |
Why?
|
| Poverty | 1 | 2011 | 2695 | 0.040 |
Why?
|
| Diagnosis, Differential | 3 | 2015 | 12968 | 0.040 |
Why?
|
| Maternal Exposure | 1 | 2006 | 1045 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 2006 | 981 | 0.040 |
Why?
|
| Duodenum | 2 | 1999 | 486 | 0.040 |
Why?
|
| Mass Screening | 2 | 2024 | 5422 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2006 | 1804 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 15840 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2005 | 2208 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2005 | 5496 | 0.040 |
Why?
|
| Indoles | 1 | 2005 | 1829 | 0.040 |
Why?
|
| Respiratory Insufficiency | 1 | 2006 | 1231 | 0.040 |
Why?
|
| Body Surface Area | 1 | 2017 | 197 | 0.030 |
Why?
|
| Nitrogen | 1 | 1998 | 350 | 0.030 |
Why?
|
| Risk Assessment | 5 | 2017 | 24102 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2005 | 1977 | 0.030 |
Why?
|
| Trauma Severity Indices | 1 | 2017 | 478 | 0.030 |
Why?
|
| Physical Exertion | 1 | 1998 | 662 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2005 | 6498 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 2825 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 5890 | 0.030 |
Why?
|
| Muscle, Skeletal | 3 | 1999 | 4924 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2016 | 15679 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 3709 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2013 | 6238 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2006 | 2496 | 0.030 |
Why?
|
| Inpatients | 2 | 2015 | 2580 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 681 | 0.030 |
Why?
|
| Physical Conditioning, Animal | 1 | 1996 | 366 | 0.030 |
Why?
|
| Fasting | 1 | 1999 | 1603 | 0.030 |
Why?
|
| Multiple Organ Failure | 1 | 2015 | 386 | 0.030 |
Why?
|
| Pleural Effusion | 1 | 2015 | 343 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2024 | 3696 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 12531 | 0.030 |
Why?
|
| Intestinal Mucosa | 3 | 1999 | 3022 | 0.020 |
Why?
|
| Time Factors | 6 | 2014 | 40139 | 0.020 |
Why?
|
| Survival Analysis | 3 | 2011 | 10185 | 0.020 |
Why?
|
| Registries | 2 | 2017 | 8458 | 0.020 |
Why?
|
| Trauma Centers | 1 | 2016 | 933 | 0.020 |
Why?
|
| Surgery Department, Hospital | 1 | 2011 | 177 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2015 | 911 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2015 | 39262 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2011 | 568 | 0.020 |
Why?
|
| Radiology Information Systems | 1 | 2014 | 528 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2024 | 3763 | 0.020 |
Why?
|
| Propensity Score | 1 | 2016 | 1926 | 0.020 |
Why?
|
| Dogs | 3 | 1999 | 3841 | 0.020 |
Why?
|
| Adolescent | 4 | 2017 | 87809 | 0.020 |
Why?
|
| Reperfusion Injury | 1 | 2015 | 1023 | 0.020 |
Why?
|
| Social Class | 1 | 2017 | 2005 | 0.020 |
Why?
|
| Potassium | 1 | 2012 | 1313 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2014 | 786 | 0.020 |
Why?
|
| Allergens | 2 | 2006 | 1402 | 0.020 |
Why?
|
| Disease Progression | 1 | 2024 | 13505 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 13262 | 0.020 |
Why?
|
| Glycogen | 2 | 1999 | 251 | 0.020 |
Why?
|
| Liver | 3 | 1999 | 7510 | 0.020 |
Why?
|
| Glycerol | 2 | 1999 | 276 | 0.020 |
Why?
|
| Hindlimb | 2 | 1999 | 510 | 0.020 |
Why?
|
| Blood Glucose | 3 | 2013 | 6379 | 0.020 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1994 | 1880 | 0.020 |
Why?
|
| United States | 2 | 2024 | 72448 | 0.020 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 1999 | 393 | 0.020 |
Why?
|
| Alanine | 2 | 1999 | 606 | 0.020 |
Why?
|
| Forecasting | 1 | 2015 | 2931 | 0.020 |
Why?
|
| Cell Proliferation | 3 | 2006 | 10442 | 0.020 |
Why?
|
| Mitogens | 1 | 2005 | 230 | 0.020 |
Why?
|
| Glucagon | 2 | 1998 | 532 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 3568 | 0.020 |
Why?
|
| Length of Stay | 2 | 2011 | 6476 | 0.020 |
Why?
|
| Lipid A | 1 | 2004 | 70 | 0.010 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2006 | 227 | 0.010 |
Why?
|
| Biopsy | 1 | 2015 | 6771 | 0.010 |
Why?
|
| Vital Capacity | 1 | 2006 | 965 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2014 | 2782 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10553 | 0.010 |
Why?
|
| Peptidoglycan | 1 | 2004 | 250 | 0.010 |
Why?
|
| Lactic Acid | 2 | 1999 | 1134 | 0.010 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2004 | 348 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 2470 | 0.010 |
Why?
|
| Qualitative Research | 1 | 2012 | 2963 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2011 | 2415 | 0.010 |
Why?
|
| Tracheostomy | 1 | 2006 | 425 | 0.010 |
Why?
|
| Infant, Newborn | 3 | 2006 | 26179 | 0.010 |
Why?
|
| Age Factors | 2 | 2015 | 18413 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2004 | 590 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10546 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 580 | 0.010 |
Why?
|
| Pain | 1 | 2015 | 5066 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2015 | 5075 | 0.010 |
Why?
|
| Antigens | 1 | 2006 | 1447 | 0.010 |
Why?
|
| Pancreatic Hormones | 1 | 1999 | 12 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2006 | 2647 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2004 | 1032 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2008 | 2007 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2004 | 1047 | 0.010 |
Why?
|
| Coronary Disease | 1 | 1994 | 5991 | 0.010 |
Why?
|
| Spleen | 1 | 2004 | 2298 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 7805 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2008 | 2634 | 0.010 |
Why?
|
| Prognosis | 2 | 2011 | 29661 | 0.010 |
Why?
|
| Incidence | 1 | 2016 | 21391 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 20080 | 0.010 |
Why?
|
| Glycogen Synthase | 1 | 1996 | 62 | 0.010 |
Why?
|
| Body Fluid Compartments | 1 | 1996 | 50 | 0.010 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2006 | 1387 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1996 | 399 | 0.010 |
Why?
|
| Splanchnic Circulation | 1 | 1996 | 110 | 0.010 |
Why?
|
| Lactates | 1 | 1996 | 404 | 0.010 |
Why?
|
| Glutamine | 1 | 1998 | 576 | 0.010 |
Why?
|
| Rheology | 1 | 1996 | 348 | 0.010 |
Why?
|
| Body Weight | 1 | 2006 | 4611 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 15286 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 1996 | 428 | 0.010 |
Why?
|
| Pregnancy | 2 | 2006 | 29746 | 0.010 |
Why?
|
| Insulin | 2 | 1998 | 6596 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2015 | 64981 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 58748 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 18955 | 0.010 |
Why?
|
| Smoking | 1 | 2006 | 9073 | 0.010 |
Why?
|
| Animals | 4 | 2004 | 167960 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2004 | 23374 | 0.000 |
Why?
|
| Mice | 1 | 2004 | 81209 | 0.000 |
Why?
|
Concepts
(222)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(38)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_